| Title |
WO number |
Status |
| Procedure for producing uronic acid block from alginate |
WO1998/51710 |
Granted, various territories |
| Use of G-block polysaccharides |
WO1998/02488 |
Granted, various territories |
| Use of oligouronates for treating mucus hyperviscosity |
WO2007/039754 |
Granted, various territories |
| Oligo-guluronate and galacturonate compositions |
WO2008/125828 |
Granted, various territories |
| Use of alginate oligomers in combating biofilms |
WO2009/068841 |
Granted, various territories |
| Parenteral pharmaceutical composition for use in gene therapy |
WO2010/109176 |
Granted, various territories |
| Composition for the administration of polymeric drugs |
WO2010/109180 |
Granted, various territories |
| Treatment of Acinetobacter with alginate oligomers and antibiotics |
WO2010/139956 |
Granted, various territories |
| Alginate oligomers for overcoming multidrug resistance in bacteria |
WO2010/139957 |
Granted, various territories |
| Use of alginate oligomers to enhance the effects of antifungal agents |
WO2013/038197 |
Granted, various territories |
| New mutant strains of Pseudomonas fluorescens and variants thereof, methods for their production, and uses thereof in alginate production |
WO2004/011628 |
Granted, various territories |
| Mucosal treatment |
WO2007/039760 |
Granted, various territories |
| Use of alginate oligomers as blood anticoagulants |
WO 2015/092437 |
Granted, various territories |
| Inhalable powder formulations of alginate oligomers |
WO 2016/030524 |
Granted, various territories |
| Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfunction |
WO 2016/151051 |
Granted, various territories |
| Bacitracin-alginate oligomer conjugates |
WO 2018073448 |
Granted, various territories |
